• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Dexcom Inc (NQ: DXCM )

    138.01 +0.14 (+0.10%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Apr 25, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 4,164,193
    Open 138.91
    Bid (Size) 126.30 (3)
    Ask (Size) 127.24 (1)
    Prev. Close 137.87
    Today's Range 134.39 - 139.24
    52wk Range 74.75 - 142.00
    Shares Outstanding 96,748,901
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    12 Health Care Stocks Moving In Thursday's After-Market Session
    Via Benzinga
    Peering Into DexCom's Recent Short Interest
    Via Benzinga

    Performance

    YTD
    +12.12%
    +12.12%
    1 Month
    -1.49%
    -1.49%
    3 Month
    +8.31%
    +8.31%
    6 Month
    +63.62%
    +63.62%
    1 Year
    +11.33%
    +11.33%

    More News

    Read More
    Dexcom Beats First-Quarter Views And Raises Sales Outlook, But Shares Crumble
    Via Investor's Business Daily
    Dexcom Reports First Quarter 2024 Financial Results
    From DexCom, Inc.
    Via Business Wire
    Staar Surgical Stock Climbs The Leadership Ladder With Jump To 84 RS Rating
    Via Investor's Business Daily
    $1000 Invested In DexCom 5 Years Ago Would Be Worth This Much Today
    Via Benzinga
    Why NASDAQ:DXCM Is a Promising High-Growth Stock in the Midst of Consolidation.
    Via Chartmill
    The Analyst Verdict: DexCom In The Eyes Of 4 Experts
    Via Benzinga
    DexCom Inc Chart Analysis
    Via Talk Markets
    3 Innovative Stocks to Buy Before Earnings Amid the Market Pullback
    Via Talk Markets
    How The Weight-Loss Bonanza Prompted A ResMed Sell-Off — But Could Soon Drive Shares Higher
    Via Investor's Business Daily
    3 Weight-Loss ETFs to Profit From the Obesity Drug Boom
    Via InvestorPlace
    Topics ETFs
    Disruptive Forces: 3 Game-changing Stocks Reshaping the Tech Landscape
    Via InvestorPlace
    Why Wall Street Got Even More Excited About The Glucose Monitor — And How Dexcom, Abbott Labs Stand To Benefit
    Via Investor's Business Daily
    Nasdaq Nightmares: 3 Stocks to Sell Before Reality Sets In
    Via InvestorPlace
    3 Obesity Drug Stocks Set to Skyrocket as Demand Goes Wild
    Via InvestorPlace
    DexCom Stock Sees IBD Stock Market Rating Sweetens Ups; Earns 83 RS Rating
    Via Investor's Business Daily
    2 Growth Stocks to Buy Hand Over Fist in April
    Via The Motley Fool
    7 Nasdaq Stocks to Sell in April Before They Crash & Burn
    Via InvestorPlace
    Dexcom Publishes Annual Sustainability Report
    From DexCom, Inc.
    Via Business Wire
    Dexcom Schedules First Quarter 2024 Earnings Release and Conference Call for April 25, 2024 at 4:30 p.m. Eastern Time
    From DexCom, Inc.
    Via Business Wire
    DexCom Stock Gains from GLP-1 Diabetic Users
    Via MarketBeat
    3 Overvalued S&P 500 Stocks for Your ‘Do NOT Buy’ List
    Via InvestorPlace
    Topics Stocks
    Exposures US Equities
    Micron, Dropbox And 2 Other Stocks Insiders Are Selling
    Via Benzinga
    Market Cap Game Show: Andy Cross vs. Bill Mann
    Via The Motley Fool
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.